Erratum (DOI:10.1016/S1473-3099(06)70520-5);Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old

Lancet Infectious Diseases

Volumn 6, Issue 7, 2006, Pages 405-410

  Jefferson, Tom ^a   Ferroni, Eliana ^b   Curtale, Filippo ^c   Giorgi Rossi, Paolo ^c   Borgia, Piero ^c  

^a Cochrane Vaccines Field ^*  (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c DEPARTMENT OF EPIDEMIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTHRITIS; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD GROUP TYPING; CINAHL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CROSS REACTION; DATA ANALYSIS; DRUG EFFICACY; EMBASE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION SENSITIVITY; MEDLINE; MORBIDITY; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; SEPTICEMIA; SEROTYPE; SINUSITIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; UNITED STATES; VACCINATION; WESTERN EUROPE;

EID: 33745461605     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70547-3     Document Type: Erratum

References (62)

1. Hausdorff W. Invasive pneumococcal disease in children: geographic and temporal variation in incidence and serotype distribution. Eur J Pediatr 161 suppl 2 (2002) S135-S139
2. Whitney C., Farley M., Handler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccaride conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
3. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 (2000) 1-35
4. Bogaert D., Veenhoven R., Sluijter M., et al. Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol 43 (2005) 74-83
5. Kaltoft, Zeuthen N., and Korandsen H. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl 89 (2000) 3-10
6. Eskola J., Takala A., Kela E., et al. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268 (1992) 3323-3327
7. Pedersen M., Hoiby E., Froholm L., et al. Systemic pneumococcal disease in Norway 1995-2001: capsular serotypes and antimicrobial resistance. Epidemiol Infect 132 (2004) 167-175
8. Dahl M., Trollfors B., Claesson B., et al. Invasive pneumococcal infections in south western Sweden: a second follow-up period of 15 years. Scand J Infect Dis 33 (2001) 667-672
9. Pineda Solas V., Pérez Benito A., Domingo Puiggros M., et al. Neumonía neumocócica bacteriémica. An Esp Pediatr 57 (2002) 408-413
10. Díez-Domingo J., Pereiró I., Morant A., et al. Epidemiology of invasive Streptococcus pneumoniae infections in children in Spain, 1996-1998. J Infect 45 (2002) 139-143
11. Dominguez A., Salleras L., Cardeñosa N., et al. The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital based study. Vaccine 20 (2002) 2989-2994
12. Iglesias Sánchez L., Pérez Yarza E., García-Arenzana J., et al. Epidemiología de la enfermedad invasive neumocócica en Guipuzcoa (1981-2001). An Esp Pediatr 57 (2002) 401-407
13. Bernaola Iturbe E., de Aristegui Fernández J., Herranz Aguirre M., et al. Estudio de la incidencia de enfermedad neumocócica invasora entre 0-5 años en el País Vasco y Navarra. An Esp Pediatr 57 (2002) 301-309
14. Espin M., Ruiz J., Navarro J., et al. Enfermedad neumocócica invasiva en niños de la Región de Murcia. Gac Sanit 16 (2002) 385-391
15. Venetz I., Schopfer K., and Mühlemann K. Paediatric invasive pneumococcal disease in Switzerland 1985-94. Int J Epidemiol 27 (1998) 1101-1104
16. Kyaw M., Clarke S., Edwards G., Jones I., and Campbell H. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125 (2000) 561-572
17. Kyaw M., Christie P., Clarke S., et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37 (2003) 1283-1291
18. Rendi-Wagner P., Georgopoulos A., Kundi M., et al. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother 53 (2004) 826-831
19. von Kries R., Siedler A., Schmitt H., and Reinert R. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31 (2000) 482-487
20. Ispahani P., Slack R., Donald F., et al. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child 89 (2004) 757-762
21. D'Ancona F., Salmaso S., Barale A., et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 23 (2005) 2492-2498
22. Miller E., Waight P., Efstratiou A., et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr 435 (2000) S11-S16
23. Smith M., Stuart J., Andrews N., et al. Invasive pneumococcal infection in south and west England. Epidemiol Infect 120 (1998) 117-123
24. Casado Flores J., Fenolo A., Aristegui Fernández J., et al. Meningitis neumocócica en niños españoles: incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico. An Esp Pediatr 57 (2002) 295-300
25. Curtale F., Mantovani J., Guerra M., et al. Rapporto sul sistema di sorveglianza delle malattie infettive e delle vaccinazioni nel lazio. Anni 2001-2004 (2005), Agenzia di Sanità Pubblica del Lazio, Rome
26. Decousser J., Pina P., Viguier F., et al. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 48 (2004) 3636-3639
27. Ekdahl K., Martensson A., Kamme C., et al. Bacteraemic pneumococcal infections in southern Sweden 1981-1996: trends in incidence, mortality, age-distribution, serogroups and penicillin resistance. Scand J Infect Dis 30 (1998) 257-262
28. Eriksson M., Henriques B., and Ekdahl K. Epidemiology of pneumococcal infections in Swedish children. Acta Paeditr 435 (2000) S35-S39
29. Esposito S., and Principi N. Epidemiologia delle meningiti, delle polmoniti e delle otiti medie pneumococciche in Italia nei soggetti di età pediatrica. Ann Ig 14 suppl 7 (2002) 7-16
30. Flamaing J., Verhaegen J., and Peetermans W. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use. J Antimicrob Chemother 50 (2002) 43-50
31. Gaudelus J., Cohen R., and Reinert P. Epidemiology of pneumococcal infections in French children. Acta Paediatr 435 (2000) S27-S29
32. Georges S., Perrocheau A., Laurent E., et al. Infections invasives à H. influenzae, L. monocytogenes, N. meningitidis, S. pneumoniae, S. agalactiae et S. pyogenes en France en 2001-2002. Bull Epid Hebdo 34 (2004) 165-168
33. Hedlund J., Sörberg M., Normark B., et al. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis 35 (2003) 452-458
34. Konradsen H., and Kaltoft M. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 9 (2002) 358-365
35. Latorre C., Genè A., Juncosa T., et al. Characterisation of invasive pneumococcal isolates in Catalan children up to 5 years of age, 1989-2000. Clin Microbiol Infect 10 (2004) 177-181
36. Muhlemann K., Matter H., Tauber M., et al. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infections, Switzerland, 1998-1999. J Infect Dis 187 (2003) 589-596
37. Nielsen S., and Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark 1989-94. Epidemiol Infect 117 (1996) 411-416
38. Pineda V., Fontanals D., Larramona H., et al. Epidemiology of invasive Streptococcus pneumoniae infections in children in an area of Barcelona, Spain. Acta Paediatr 91 (2002) 1251-1256
39. Prymula R., Motlova J., and Kriz P. Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic. Indian J Med Res 119 suppl (2004) 168-170
40. Reinert R., Kaufhold A., Schlaeger J., Mechery V., and Lutticken R. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Pediatr Infect Dis J 16 (1997) 244-245
41. Serrano I., Ramirez M., and Melo-Cristino J. The Portuguese Surveillance Group for the Study of Respiratory Pathogens. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy. Clin Microbiol Infect 10 (2004) 652-656
42. Sleeman K., Knox K., George R., et al. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 183 (2001) 239-246
43. Syriopoulou V., Daikos G., Soulis K., et al. Epidemiology of invasive childhood pneumococcal infections in Greece. Acta Paediatr 435 (2000) S30-S34
44. Urwin G., Yuan M., Hall L., Brown K., Efstratiou A., and Feldman R. Pneumococcal meningitis in the north east Thames region UK: epidemiology and molecular analysis of isolates. Epidemiol Infect 117 (1996) 95-102
45. Zissis N., Syriopoulou V., Kafetzis D., et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Paediatr 163 (2004) 364-368
46. Yu X., Gray B., Chang S., et al. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis 180 (1999) 1569-1576
47. Robbins J., Austrian R., Lee C., et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148 (1983) 1136-1159
48. Bergan T. Antibiotic usage in Nordic countries. Int J Antimicrob Agents 18 (2001) 279-282
49. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, Twelfth informational supplement. Standard M100-S12 (2002), NCCLS, Wayne, PA
50. Trotter C., Samuelsson S., Perrocheau A., et al. Ascertainment of meningococcal disease in Europe. Euro Surveill 10 (2005) 247-250
51. Faustini A., Fano V., Sangalli M., et al. Estimating incidence of bacterial meningitis with capture-recapture method, Lazio region, Italy. Eur J Epidemiol 16 (2000) 843-848
52. Sniadak D., Schwaertz B., Lipman H., et al. Potential intervention for the prevention of childhood pneumoniae: geographic and temporal differences in serotype and serogroup distribution of sterile sites pneumococcal isolates from children - implication for vaccine strategies. Pediatr Infect Dis J 14 (1995) 503-510
53. Hausdorff W., Bryant J., Paradiso P., and Siber G. Which pneumococcal serogroup cause the most invasive disease: implication for conjugate vaccine formulation and use, part I. Clin Infect Dis 30 (2000) 100-121
54. Vakevainen M., Eklund C., Eskola J., and Kayhty H. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis 184 (2001) 789-793
55. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 161 (2002) 188-195
56. Byington C., Samore M., Stoddard G., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of non vaccine serogroups. Clin Infect Dis 41 (2005) 21-29
57. Centers for Disease Control and Prevention (CDC). Direct and in direct effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 893-897
58. Schutze G., Tucker N., and Mason E. Impact of the conjugate pneumococcal vaccine in Arkansas. Pediatr Infect Dis J 23 (2004) 1125-1129
59. Obaro S., Adegbola R., Banya W., and Greenwood B. Carriage of pneumococci after pneumococcal vaccination. Lancet 348 (1996) 271-272
60. Dagan R., Givon-Lavi N., Zamir O., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 (2002) 927-936
61. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
62. Schuchat A., Robinson K., Wenger J., et al. Bacterial meningitis in the United States in 1995. N Engl J Med 337 (1997) 970-976